Cargando…

Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis

Breast cancer (BC) is one of the leading causes of cancer-related deaths in women. The purpose of this study is to identify key molecular markers related to the diagnosis and prognosis of early breast cancer (EBC). The data of mRNA, lncRNA and DNA methylation were downloaded from The Cancer Genome A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenshan, Wang, Haoqi, Qi, Yixin, Li, Sainan, Geng, Cuizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821628/
https://www.ncbi.nlm.nih.gov/pubmed/35132081
http://dx.doi.org/10.1038/s41598-022-05486-3
_version_ 1784646440739405824
author Zhang, Wenshan
Wang, Haoqi
Qi, Yixin
Li, Sainan
Geng, Cuizhi
author_facet Zhang, Wenshan
Wang, Haoqi
Qi, Yixin
Li, Sainan
Geng, Cuizhi
author_sort Zhang, Wenshan
collection PubMed
description Breast cancer (BC) is one of the leading causes of cancer-related deaths in women. The purpose of this study is to identify key molecular markers related to the diagnosis and prognosis of early breast cancer (EBC). The data of mRNA, lncRNA and DNA methylation were downloaded from The Cancer Genome Atlas (TCGA) dataset for identification of differentially expressed mRNAs (DEmRNAs), differentially expressed lncRNAs (DElncRNAs) and DNA methylation analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyzes were used to identify the biological functions of DEmRNAs. The correlation analysis between DNA methylation and DEmRNAs was carried out. Then, diagnostic analysis and prognostic analysis of identified DEmRNAs and DElncRNAs were also performed in the TCGA database. Subsequently, methylation state verification for identified DEmRNAs was performed in the GSE32393 dataset. In addition, real-time polymerase chain reaction (RT-PCR) in vitro verification of genes was performed. Finally, AC093110.1 was overexpressed in human BC cell line MCF-7 to verify cell proliferation and migration. In this study, a total of 1633 DEmRNAs, 750 DElncRNAs and 8042 differentially methylated sites were obtained, respectively. In the Venn analysis, 11 keys DEmRNAs (ALDH1L1, SPTBN1, MRGPRF, CAV2, HSPB6, PITX1, WDR86, PENK, CACNA1H, ALDH1A2 and MME) were we found. ALDH1A2, ALDH1L1, HSPB6, MME, MRGPRF, PENK, PITX1, SPTBN1, WDR86 and CAV2 may be considered as potential diagnostic gene biomarkers in EBC. Strikingly, CAV2, MME, AC093110.1 and AC120498.6 were significantly actively correlated with survival. Methylation state of identified DEmRNAs in GSE32393 dataset was consistent with the result in TCGA. AC093110.1 can affect the proliferation and migration of MCF-7. ALDH1A2, ALDH1L1, HSPB6, MME, MRGPRF, PENK, PITX1, SPTBN1, WDR86 and CAV2 may be potential diagnostic gene biomarkers of EBC. Strikingly, CAV2, MME, AC093110.1 and AC120498.6 were significantly actively correlated with survival. The identification of these genes can help in the early diagnosis and treatment of EBC. In addition, AC093110.1 can regulate SPTBN1 expression and play an important role in cell proliferation and migration, which provides clues to clarify the regulatory mechanism of EBC.
format Online
Article
Text
id pubmed-8821628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88216282022-02-09 Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis Zhang, Wenshan Wang, Haoqi Qi, Yixin Li, Sainan Geng, Cuizhi Sci Rep Article Breast cancer (BC) is one of the leading causes of cancer-related deaths in women. The purpose of this study is to identify key molecular markers related to the diagnosis and prognosis of early breast cancer (EBC). The data of mRNA, lncRNA and DNA methylation were downloaded from The Cancer Genome Atlas (TCGA) dataset for identification of differentially expressed mRNAs (DEmRNAs), differentially expressed lncRNAs (DElncRNAs) and DNA methylation analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyzes were used to identify the biological functions of DEmRNAs. The correlation analysis between DNA methylation and DEmRNAs was carried out. Then, diagnostic analysis and prognostic analysis of identified DEmRNAs and DElncRNAs were also performed in the TCGA database. Subsequently, methylation state verification for identified DEmRNAs was performed in the GSE32393 dataset. In addition, real-time polymerase chain reaction (RT-PCR) in vitro verification of genes was performed. Finally, AC093110.1 was overexpressed in human BC cell line MCF-7 to verify cell proliferation and migration. In this study, a total of 1633 DEmRNAs, 750 DElncRNAs and 8042 differentially methylated sites were obtained, respectively. In the Venn analysis, 11 keys DEmRNAs (ALDH1L1, SPTBN1, MRGPRF, CAV2, HSPB6, PITX1, WDR86, PENK, CACNA1H, ALDH1A2 and MME) were we found. ALDH1A2, ALDH1L1, HSPB6, MME, MRGPRF, PENK, PITX1, SPTBN1, WDR86 and CAV2 may be considered as potential diagnostic gene biomarkers in EBC. Strikingly, CAV2, MME, AC093110.1 and AC120498.6 were significantly actively correlated with survival. Methylation state of identified DEmRNAs in GSE32393 dataset was consistent with the result in TCGA. AC093110.1 can affect the proliferation and migration of MCF-7. ALDH1A2, ALDH1L1, HSPB6, MME, MRGPRF, PENK, PITX1, SPTBN1, WDR86 and CAV2 may be potential diagnostic gene biomarkers of EBC. Strikingly, CAV2, MME, AC093110.1 and AC120498.6 were significantly actively correlated with survival. The identification of these genes can help in the early diagnosis and treatment of EBC. In addition, AC093110.1 can regulate SPTBN1 expression and play an important role in cell proliferation and migration, which provides clues to clarify the regulatory mechanism of EBC. Nature Publishing Group UK 2022-02-07 /pmc/articles/PMC8821628/ /pubmed/35132081 http://dx.doi.org/10.1038/s41598-022-05486-3 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Wenshan
Wang, Haoqi
Qi, Yixin
Li, Sainan
Geng, Cuizhi
Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title_full Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title_fullStr Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title_full_unstemmed Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title_short Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
title_sort epigenetic study of early breast cancer (ebc) based on dna methylation and gene integration analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821628/
https://www.ncbi.nlm.nih.gov/pubmed/35132081
http://dx.doi.org/10.1038/s41598-022-05486-3
work_keys_str_mv AT zhangwenshan epigeneticstudyofearlybreastcancerebcbasedondnamethylationandgeneintegrationanalysis
AT wanghaoqi epigeneticstudyofearlybreastcancerebcbasedondnamethylationandgeneintegrationanalysis
AT qiyixin epigeneticstudyofearlybreastcancerebcbasedondnamethylationandgeneintegrationanalysis
AT lisainan epigeneticstudyofearlybreastcancerebcbasedondnamethylationandgeneintegrationanalysis
AT gengcuizhi epigeneticstudyofearlybreastcancerebcbasedondnamethylationandgeneintegrationanalysis